028260.KS
Latest Trade
122,000.00KRWChange
-2,000.00(-1.61%)Volume
511,499Today's Range
-
123,000.0052 Week Range
-
160,000.00As of on the Korea Stock Exchange ∙ Minimum 15 minute delay
Previous Close | 124,000.00 |
|---|---|
Open | 122,000.00 |
Volume | 511,499 |
3M AVG Volume | 19.96 |
Today's High | 123,000.00 |
Today's Low | 121,000.00 |
52 Week High | 160,000.00 |
52 Week Low | 73,500.00 |
Shares Out (MIL) | 164.93 |
Market Cap (MIL) | 23,359,520.00 |
Forward P/E | 18.83 |
Dividend (Yield %) | 1.85 |
Samsung C&T Q1 Operating Profit Falls 49.7 Percent Y/Y
Samsung C&T Signs 1.5 Trln Won Contract With Samsung Electronics
Samsung C&T 2018 Q4 Operating Profit Down 14.3 Pct Y/Y
Samsung C&T Corp is a Korea-based company principally engaged in the trading of industrial goods. The Company operates its business through six segments. The Trading segment is mainly engaged in the trading of chemicals, steel, natural materials, and living materials, among others. The Construction segment constructs office buildings, roads and railways, gas-fired power plants, coal-fired power plants, nuclear power plants, and houses, among others. The Food and Food Distribution segment is engaged in the provision of food services and the distribution of food materials. The Fashion segment mainly processes and sells clothing and accessories. The Resort segment is mainly engaged in the operation of theme parks, golf courses and others, and the landscaping. The Bio segment mainly produces biopharmaceuticals.
Industry
Chemical Manufacturing
Executive Leadership
Chi Hun Choi
Executive Chairman of the Board
Jeong Seok Goh
Co-President, Co-Chief Executive Officer, Director
Yeong Ho Lee
Co-President, Co-Chief Executive Officer, Director
Geum Yong Jung
Co-Chief Executive Officer, Vice President, Director
Ahmad Khalid Abdelrazaq
Executive Vice President
Price To Earnings (TTM) | 18.02 |
|---|---|
Price To Sales (TTM) | 0.79 |
Price To Book (MRQ) | 0.84 |
Price To Cash Flow (TTM) | 13.15 |
Total Debt To Equity (MRQ) | 17.35 |
LT Debt To Equity (MRQ) | 4.59 |
Return on Investment (TTM) | 3.97 |
Return on Equity (TTM) | 2.76 |
Shares in Samsung Electronics and affiliates rebounded on Tuesday, reversing losses stemming from Samsung Electronics Vice Chairman Jay Y. Lee's receiving a two-and-a-half year prison term on Monday.
Samsung C&T Corp and Samsung Electronics Co Ltd have almost doubled the size of a contract related to the construction of a semiconductor production line, taking the project's total cost to 1.46 trillion won ($1.29 billion).
Two Samsung Group affiliates said they are selling their entire stakes worth a combined $867 million in Samsung's de facto holding company, as South Korea's biggest conglomerate faces government pressure to unwind group cross-shareholdings.
Two Samsung Group affiliates said on Thursday they had decided to sell their stakes in Samsung C&T Corp worth around a combined 971 billion won ($866.57 million).
South Korean prosecutors are looking into U.S. activist fund Elliott Management to see if it violated disclosure rules during the fund's 2015 purchase of shares in Samsung C&T Corp <028260.KS>, an official with the prosecution said on Thursday.
South Korea's Samsung C&T said on Thursday that it had picked Bain Capital as the preferred bidder for its stake in Hanwha General Chemical.
* Says it plans to sell its entire 4,042,758 shares of Samsung C&T Corporation for 582.16 billion won
South Korea's Samsung SDI <006400.KS> said on Tuesday it would sell shares worth 582 billion won ($546 million) in affiliate Samsung C&T Corp <028260.KS> to resolve cross-shareholding ties and secure funds for investment.
South Korea's Samsung SDI said on Tuesday it is selling shares worth 582 billion won ($546 million) in affiliate Samsung C&T Corp .
Samsung C&T Corp <028260.KS> said on Tuesday it has no plan currently to purchase shares in Samsung Bioepis Co, after a report said the company is considering raising up to 3 trillion won ($2.8 billion) to buy a 30 percent stake in its biopharma affiliate.
Shares in Samsung C&T Corp rose 3.6 percent on Tuesday after a report said the company is considering raising up to 3 trillion won ($2.8 billion) to buy a 30 percent stake in biopharma affiliate Samsung Bioepis Co Ltd.
Samsung C&T Corp, de facto holding company of Samsung Group, is considering raising up to 3 trillion won ($2.8 billion) to buy a 30 percent stake in sub-subsidiary Samsung Bioepis Co Ltd, a South Korean TV channel reported on Monday.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.